![Volker Wedershoven](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Volker Wedershoven is currently the Chief Executive Officer at ImevaX.
GmbH.
He previously worked as a Director at ArcticZymes Technologies ASA. He holds an MBA from Ludwig-Maximilians-Universität München.
| Sociétés | Poste | Début |
|---|---|---|
ImevaX GmbH
 ImevaX GmbH BiotechnologyHealth Technology Develops vaccines against pathogens of chronic infectious diseases | Directeur Général | - |
| Sociétés | Poste | Fin |
|---|---|---|
| ARCTICZYMES TECHNOLOGIES ASA | Directeur/Membre du Conseil | 24/10/2022 |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 3 |
|---|---|
ArcticZymes Technologies ASA
 ArcticZymes Technologies ASA Medical SpecialtiesHealth Technology Develops and manufactures immune modulating compounds | Health Technology |
Ludwig-Maximilians-Universität München
 Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ImevaX GmbH
ImevaX GmbH BiotechnologyHealth Technology Develops vaccines against pathogens of chronic infectious diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
